Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?

Clin Microbiol Infect. 2011 Aug;17(8):1126-7. doi: 10.1111/j.1469-0691.2011.03579.x. Epub 2011 Jun 20.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Antitubercular Agents / pharmacology*
  • Bacterial Proteins / biosynthesis*
  • Carbapenems / therapeutic use*
  • Drug Resistance, Bacterial*
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Mycobacterium tuberculosis / drug effects*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects*
  • beta-Lactamases / biosynthesis*

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Bacterial Proteins
  • Carbapenems
  • beta-Lactamases
  • carbapenemase